Role of JMJD3 Demethylase and Its Inhibitor GSK-J4 in Regulation of MGMT, TRA2A, RPS6KA2 and U2AF1 Genes in Prostate Cancer Cell Lines.

Diagenode

EN | | | / Search

Products
Shearing technologies
Automation
- IP-Star accessories
Chromatin studies
DNA methylation
Genome editing (CRISPR/Cas9)
- Selection of guide RNA by ChIP
Antibodies
NGS Library preparation
Exosomes
Reagents
- Primer indexes for tagmented libraries
Services
Epigenomics Profiling Services
Epigenomics Data Analysis Service
Research areas
Resources
- Protocols
- Publications
- Documents
- Testimonials
- Media pack
- Videos
- Webinars
Company
- About us
- Events
- News
- Careers
- Scientific programs
Contact
- Sales and Technical Support
- How to find us?

Role of JMJD3 Demethylase and Its Inhibitor GSK-J4 in Regulation of MGMT, TRA2A, RPS6KA2 and U2AF1 Genes in Prostate Cancer Cell Lines.

Sanchez A. et al.

Abstract not availabale

Tags
Antibody

Share this article
Tweet

Published
August, 2020

Products used in this publication

C15410195

H3K27me3 Antibody
C15410206

Rabbit IgG

Tweets by Diagenode

Events

APHL 2024
Milwaukee, Wisconsin, USA
May 6-May 9, 2024

News

See all news

The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.

Site map | Contact us | Conditions of sales | Conditions of purchase | Privacy policy | Diagenode Diagnostics